Soft Gel Capsules for API Delivery

What are soft gel capsules?

Soft gel capsule refers to a certain amount of liquid drug directly enveloped, or solid drug dissolved or dispersed in a suitable excipient prepared into a solution, suspension, emulsion or semi-solid, sealed in the soft capsule material made of capsules. The dosage form is mostly suitable for small doses, water insolubility, light sensitivity, moisture and heat instability and easy oxidation and volatile drugs, with its accurate content, beautiful appearance, sealing safety, cover up bad odor and high bioavailability advantages, has been widely used in pharmaceutical, food, cosmetics and other fields.

Prescription of soft gel capsules

The prescription of soft capsules is mainly composed of two parts: content and capsule shell:

The contents include active ingredients (APIs), solvents, dispersants, etc. The contents are in a liquid state and are mainly divided into solutions, suspensions, and emulsions. Commonly used content thinners are vegetable oils, polyethylene glycols, etc., and solubilizers, antioxidants, etc. are added according to demand. Some eating methods include chewable soft capsules with sweeteners added to the contents. No matter what diluent or excipient added, its impact on the API needs to be considered. According to the nature of the API and the selection of different diluents, the solubility and stability of the API need to be considered. At the same time, the stability and uniformity of the components in the liquid medicine need to be examined during the preparation and pelletizing process.

The capsule formulation contains gelatin, thickeners, plasticizers, purified water, etc., and preservatives, sunscreens, pigments, etc. can also be added according to needs.

Related formulation services at BOC Sciences

Advantages of soft gel capsules

Enhanced bioavailability: Bioavailability is one of the most critical factors influencing the effectiveness of oral medications. Many drugs, particularly those that are poorly water-soluble, face significant absorption challenges in the gastrointestinal tract. Soft gel capsules can improve the solubility of these drugs by dissolving quickly in the stomach and releasing the API in a solubilized form. This enhanced dissolution rate leads to better absorption and, consequently, higher bioavailability.

For instance, in the case of oncology drugs, which often include highly lipophilic molecules, soft gel capsules offer a superior delivery system compared to traditional oral dosage forms. By encapsulating the API in a lipid-based formulation, soft gels facilitate better absorption of the drug across the intestinal wall, enabling more effective cancer treatment.

Patient compliance: One of the primary reasons for the growing popularity of soft gel capsules is their patient-friendly nature. Unlike tablets or hard capsules, soft gel capsules are easier to swallow, especially for individuals who may have difficulty with large pills or those who suffer from conditions like dysphagia (difficulty swallowing). The smooth, gelatinous texture makes soft gels a preferred choice for both children and elderly patients.

Moreover, soft gel capsules can significantly improve patient adherence to prescribed regimens. Since they are perceived as more convenient and pleasant to take, soft gels help reduce the likelihood of missed doses and treatment interruptions, ultimately contributing to better clinical outcomes.

Dose uniformity: In the pharmaceutical industry, achieving consistent dosing is paramount, especially for drugs that require precise titration, such as those used in chronic disease management or cancer therapy. Soft gel capsules excel in this area due to their ability to uniformly encapsulate liquid or semi-solid drug formulations. This ensures that each capsule contains the same precise dose of API, reducing the risks associated with dosing errors, especially in low-dose or high-potency drugs.

Drug stability: The stability of the API within a drug formulation is crucial to its efficacy. Soft gel capsules provide a protective barrier, preventing exposure to air, light, and moisture, all of which can degrade the API over time. This is especially important for lipid-based formulations, which are susceptible to oxidation. The hermetically sealed soft gel capsule preserves the integrity of the drug, extending its shelf life and ensuring that patients receive the full therapeutic benefit throughout the product's lifespan.

When to choose soft gel capsules for your API?

Combination of APIs

The rising demand for combination drug products, such as Fixed-Dose Combinations (FDCs), has further highlighted the utility of soft gel capsules. These formulations allow multiple APIs to be combined into a single dose, improving patient convenience and adherence to treatment regimens. Soft gels are particularly well-suited for such products because they provide a uniform distribution of APIs within a liquid or semi-solid matrix. This ensures consistent dosing and simplifies manufacturing processes. FDCs in soft gel form are commonly used for chronic conditions like hypertension, diabetes, and cardiovascular diseases, where the need for multi-drug regimens is common.

Controlled release systems

Soft gel capsules are highly adaptable for controlled-release drug delivery, offering various mechanisms such as immediate release, sustained release, and delayed release. Immediate-release formulations ensure rapid onset of action, while sustained-release capsules maintain therapeutic drug levels over an extended period, reducing dosing frequency. For drugs requiring targeted delivery, delayed-release formulations protect the API until it reaches the desired site of action in the gastrointestinal tract. The flexibility in designing these release profiles makes soft gels a preferred choice for addressing diverse therapeutic needs.

Deliver high potent and toxic APIs

High-potency APIs, such as those used in oncology, autoimmune diseases, and hormonal therapies, present unique formulation challenges. Soft gel capsules effectively address these challenges by encapsulating the API in a liquid matrix, reducing the risk of airborne exposure during manufacturing. This feature is particularly critical for drugs with narrow therapeutic indices, where precise dosing and minimal contamination risks are paramount. Furthermore, the sealed nature of soft gels protects HPAPIs from environmental factors, ensuring stability and efficacy.

Deliver poorly water-soluble APIs

Lipid-based formulations, a cornerstone of soft gel technology, are ideal for delivering poorly water-soluble drugs. Soft gels provide a compatible environment for lipid excipients, which aid in solubilizing APIs and improving their bioavailability. Additionally, the absence of headspace within the capsule minimizes oxidation, preserving the integrity of APIs sensitive to air and light. Lipid-based soft gels are particularly effective for drugs requiring rapid dissolution in the gastrointestinal tract, ensuring that the API remains solubilized for optimal absorption.